Polypeptides derived from endostatin exhibiting...

Details Polypeptides derived from endostatin exhibiting... Polypeptides derived from endostatin exhibiting...

2005-07-26

2005-07-26

Tate, Christopher (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C530S300000, C530S324000

Reexamination Certificate

active

06921749

ABSTRACT:
Polypeptides with sequence corresponding or homologous to that of endostatin, having inhibiting activity on angiogenesis, are useful in the treatment of angiogenesis-dependent tumors.

REFERENCES:
patent: 6342219 (2002-01-01), Thorpe et al.
patent: 6630448 (2003-10-01), O'Reilly et al.
patent: WO 97/15666 (1997-05-01), None
patent: WO 99/29855 (1999-06-01), None
patent: WO 99/48924 (1999-09-01), None

Affiliated with

Also associated with

Rating

Polypeptides derived from endostatin exhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptides derived from endostatin exhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides derived from endostatin exhibiting... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3432883